Predicting Adverse Drug Events Using Pharmacological Network Models
Authors:
- 21 December 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (114) , 114ra127
Abstract
A network-based method that uses available pharmacosafety data can predict yet-to-be-discovered adverse drug events to help reduce drug-associated morbidity and mortality.Keywords
This publication has 39 references indexed in Scilit:
- Role of systems pharmacology in understanding drug adverse eventsWIREs Mechanisms of Disease, 2010
- EIDOSDrug Safety, 2010
- Predicting new molecular targets for known drugsNature, 2009
- Network analyses in systems pharmacologyBioinformatics, 2009
- Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug EventsClinical Pharmacology & Therapeutics, 2009
- The Knowledge-Integrated Network Biomarkers Discovery for Major Adverse Cardiac EventsJournal of Proteome Research, 2008
- Drug Target Identification Using Side-Effect SimilarityScience, 2008
- Prediction of drug–target interaction networks from the integration of chemical and genomic spacesBioinformatics, 2008
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profilingBritish Journal of Pharmacology, 2007
- Pharma's year of trouble and strifeNature Reviews Drug Discovery, 2006